The device is designed to replace the standard plastic tibial trial spacer and uses proprietary technology to give surgeons real-time feedback on limb alignment and implant position.
OrthoSensor also announced recently that Stryker’s orthopedics division will co-market the VERASENSE.
More Articles on Devices:
Professor Moshe Shoham Receives Award for Inventing Renaissance Robotic System
Jury Sides with Depuy-Synthes in $16M Patent Infringement Ruling Against Globus
Medtronic Receives CE Mark, Initiates European Launch of Spinal Deformity Instrument
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
